Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Iron Versus Oral Iron Versus No Iron With or Without Erythropoiesis‐ Stimulating Agents (ESA) for Cancer Patients With Anaemia: a Systematic Review and Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434700/all/Intravenous_iron_versus_oral_iron_versus_no_iron_with_or_without_erythropoiesis‐_stimulating_agents__ESA__for_cancer_patients_with_anaemia:_a_systematic_review_and_network_meta‐analysis.
Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434700/all/Intravenous_iron_versus_oral_iron_versus_no_iron_with_or_without_erythropoiesis‐_stimulating_agents__ESA__for_cancer_patients_with_anaemia:_a_systematic_review_and_network_meta‐analysis. Accessed February 18, 2025.
Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434700/all/Intravenous_iron_versus_oral_iron_versus_no_iron_with_or_without_erythropoiesis‐_stimulating_agents__ESA__for_cancer_patients_with_anaemia:_a_systematic_review_and_network_meta‐analysis
Intravenous Iron Versus Oral Iron Versus No Iron With or Without Erythropoiesis‐ Stimulating Agents (ESA) for Cancer Patients With Anaemia: a Systematic Review and Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434700/all/Intravenous_iron_versus_oral_iron_versus_no_iron_with_or_without_erythropoiesis‐_stimulating_agents__ESA__for_cancer_patients_with_anaemia:_a_systematic_review_and_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis
ID - 434700
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434700/all/Intravenous_iron_versus_oral_iron_versus_no_iron_with_or_without_erythropoiesis‐_stimulating_agents__ESA__for_cancer_patients_with_anaemia:_a_systematic_review_and_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -